EXOZ
EXOZYMES INC.
NASDAQ · Healthcare · Biotechnology · US
$4.00
−5.33%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 20, 2026
- EPS actual
- -$0.33
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 20, 2026 | — | -$0.33 | — | — |
| May 14, 2026 | — | -$0.28 | — | — |
| Mar 30, 2026 | — | -$0.31 | — | — |
| Nov 13, 2025 | — | -$0.27 | — | — |
| Aug 12, 2025 | — | -$0.28 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026